PortfoliosLab logoPortfoliosLab logo
WDNA vs. FBIOX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

WDNA vs. FBIOX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WisdomTree BioRevolution Fund (WDNA) and Fidelity Select Biotechnology Portfolio (FBIOX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, WDNA achieves a 13.32% return, which is significantly higher than FBIOX's 11.03% return.


WDNA

1D
0.49%
1M
8.93%
YTD
13.32%
6M
11.11%
1Y
50.90%
3Y*
5.47%
5Y*
-5.03%
10Y*

FBIOX

1D
2.80%
1M
6.82%
YTD
11.03%
6M
8.61%
1Y
58.91%
3Y*
20.04%
5Y*
6.76%
10Y*
11.69%
*Multi-year figures are annualized to reflect compound growth (CAGR)

WDNA vs. FBIOX - Yearly Performance Comparison


2026 (YTD)20252024202320222021
WDNA
WisdomTree BioRevolution Fund
13.32%22.68%-14.18%-2.07%-26.29%-4.92%
FBIOX
Fidelity Select Biotechnology Portfolio
11.03%36.38%7.26%10.09%-15.87%-2.57%

Correlation

The correlation between WDNA and FBIOX is 0.80, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.80

Correlation (3Y)
Calculated over the trailing 3-year period

0.83

Correlation (5Y)
Calculated over the trailing 5-year period

0.87

Correlation (All Time)
Calculated using the full available price history since Jun 3, 2021

0.87

The correlation between WDNA and FBIOX has been stable across timeframes, ranging from 0.80 to 0.87 - a consistent structural relationship.

WDNA vs. FBIOX - Sectors Allocation Comparison


Sectors
WDNA
FBIOX

Healthcare

85.0%
100.0%

Basic Materials

6.5%

-

Consumer Defensive

3.0%

-

Energy

1.1%

-

Communication Services

-

-

Consumer Cyclical

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

WDNA
85.0%
FBIOX
100.0%

Basic Materials

WDNA
6.5%
FBIOX

-

Consumer Defensive

WDNA
3.0%
FBIOX

-

Energy

WDNA
1.1%
FBIOX

-

Communication Services

WDNA

-

FBIOX

-

Consumer Cyclical

WDNA

-

FBIOX

-

Financial Services

WDNA

-

FBIOX

-

Industrials

WDNA

-

FBIOX

-

Real Estate

WDNA

-

FBIOX

-

Technology

WDNA

-

FBIOX

-

Utilities

WDNA

-

FBIOX

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WDNA vs. FBIOX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WDNA
WDNA Risk / Return Rank: 6666
Overall Rank
WDNA Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
WDNA Sortino Ratio Rank: 6666
Sortino Ratio Rank
WDNA Omega Ratio Rank: 5656
Omega Ratio Rank
WDNA Calmar Ratio Rank: 8585
Calmar Ratio Rank
WDNA Martin Ratio Rank: 5959
Martin Ratio Rank

FBIOX
FBIOX Risk / Return Rank: 8888
Overall Rank
FBIOX Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
FBIOX Sortino Ratio Rank: 8484
Sortino Ratio Rank
FBIOX Omega Ratio Rank: 7373
Omega Ratio Rank
FBIOX Calmar Ratio Rank: 9898
Calmar Ratio Rank
FBIOX Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WDNA vs. FBIOX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and Fidelity Select Biotechnology Portfolio (FBIOX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


WDNAFBIOXDifference
Sharpe ratioReturn per unit of total volatility

-0.76

Sortino ratioReturn per unit of downside risk

-0.84

Omega ratioGain probability vs. loss probability

1.32

1.44

-0.12

Calmar ratioReturn relative to maximum drawdown

4.37

7.66

-3.29

Martin ratioReturn relative to average drawdown

9.80

23.32

-13.52

WDNA vs. FBIOX - Sharpe Ratio Comparison

The current WDNA Sharpe Ratio is 1.98, which is comparable to the FBIOX Sharpe Ratio of 2.74. The chart below compares the historical Sharpe Ratios of WDNA and FBIOX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

WDNA vs. FBIOX - Drawdown Comparison

The maximum WDNA drawdown since its inception was -58.87%, smaller than the maximum FBIOX drawdown of -71.98%. Use the drawdown chart below to compare losses from any high point for WDNA and FBIOX.


Loading charts...

Drawdown Indicators


WDNAFBIOXDifference

Max Drawdown

Largest peak-to-trough decline

-58.87%

-71.98%

+13.11%

Max Drawdown (1Y)

Largest decline over 1 year

-11.70%

-7.62%

-4.08%

Max Drawdown (3Y)

Largest decline over 3 years

-38.25%

-27.83%

-10.42%

Max Drawdown (5Y)

Largest decline over 5 years

-58.87%

-44.87%

-14.00%

Max Drawdown (10Y)

Largest decline over 10 years

-48.66%

Current Drawdown

Current decline from peak

-27.05%

0.00%

-27.05%

Average Drawdown

Average peak-to-trough decline

-35.56%

-23.60%

-11.96%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.21%

2.50%

+2.71%

Volatility

WDNA vs. FBIOX - Volatility Comparison

The current volatility for WisdomTree BioRevolution Fund (WDNA) is 7.39%, while Fidelity Select Biotechnology Portfolio (FBIOX) has a volatility of 8.04%. This indicates that WDNA experiences smaller price fluctuations and is considered to be less risky than FBIOX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WDNAFBIOXDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.39%

8.04%

-0.65%

Volatility (6M)

Calculated over the trailing 6-month period

16.98%

17.08%

-0.10%

Volatility (1Y)

Calculated over the trailing 1-year period

25.90%

21.36%

+4.54%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.14%

25.03%

+0.11%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.06%

26.26%

-1.20%

WDNA vs. FBIOX - Expense Ratio Comparison

WDNA has a 0.45% expense ratio, which is lower than FBIOX's 0.69% expense ratio.


Dividends

WDNA vs. FBIOX - Dividend Comparison

WDNA's dividend yield for the trailing twelve months is around 4.03%, less than FBIOX's 6.06% yield.


PositionTTM20252024202320222021202020192018201720162015
FBIOX
Fidelity Select Biotechnology Portfolio
6.06%2.47%1.21%0.45%0.00%14.48%19.46%8.89%11.18%1.41%3.42%6.71%
WDNA
WisdomTree BioRevolution Fund
4.03%4.57%0.75%0.80%0.38%0.10%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


WDNA and FBIOX have a correlation of 0.80, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FBIOX has higher volatility (8.04%) compared to WDNA (7.39%). In terms of maximum drawdown, WDNA dropped -58.87% vs FBIOX's -71.98%.

FBIOX currently has the higher Sharpe Ratio (2.74 vs 1.98), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for WDNA and FBIOX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer